• BIO-key shares to move to OTC Markets for quotation May 13 under symbol BKYI, following Nasdaq trading suspension effective at today’s market close.
• Suspension tied to failure to meet Nasdaq’s $1 minimum bid requirement for at least 10 consecutive sessions by May 4, despite bid price holding above $1 for past eight sessions.
• Nasdaq action also reflects delay in filing annual report on Form 10-K for year ended Dec. 31, 2025.
• Company plans to seek a Nasdaq hearings panel review aimed at restoring Nasdaq listing, with no assurance of reinstatement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-016455), on May 12, 2026, and is solely responsible for the information contained therein.